These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 26513855)

  • 1. Comparing UK, USA and Australian values for EQ-5D as a health utility measure of oral health.
    Brennan DS; Teusner DN
    Community Dent Health; 2015 Sep; 32(3):180-4. PubMed ID: 26513855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Health Impact Profile, EuroQol, and Assessment of Quality of Life instruments as quality of life and health-utility measures of oral health.
    Brennan DS
    Eur J Oral Sci; 2013 Jun; 121(3 Pt 1):188-93. PubMed ID: 23659242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. US and UK versions of the EQ-5D preference weights: does choice of preference weights make a difference?
    Huang IC; Willke RJ; Atkinson MJ; Lenderking WR; Frangakis C; Wu AW
    Qual Life Res; 2007 Aug; 16(6):1065-72. PubMed ID: 17415683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity of the AusTOM scales: a comparison of the AusTOMs and EuroQol-5D.
    Unsworth CA; Duckett SJ; Duncombe D; Perry A; Skeat J; Taylor N
    Health Qual Life Outcomes; 2004 Nov; 2():64. PubMed ID: 15541181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of generic, condition-specific, and mapped health state utility values for multiple myeloma cancer.
    Rowen D; Young T; Brazier J; Gaugris S
    Value Health; 2012 Dec; 15(8):1059-68. PubMed ID: 23244808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages?
    Rutten-van Mölken MP; Oostenbrink JB; Tashkin DP; Burkhart D; Monz BU
    Chest; 2006 Oct; 130(4):1117-28. PubMed ID: 17035446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of FACT- and EQ-5D-based utility scores in cancer.
    Pickard AS; Ray S; Ganguli A; Cella D
    Value Health; 2012; 15(2):305-11. PubMed ID: 22433762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of EQ-5D-3L population norms in Queensland, Australia, estimated using utility value sets from Australia, the UK and USA.
    Clemens S; Begum N; Harper C; Whitty JA; Scuffham PA
    Qual Life Res; 2014 Oct; 23(8):2375-81. PubMed ID: 24676898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of EQ-5D index scores using the UK, US, and Japan preference weights in a Thai sample with type 2 diabetes.
    Sakthong P; Charoenvisuthiwongs R; Shabunthom R
    Health Qual Life Outcomes; 2008 Sep; 6():71. PubMed ID: 18811935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The responsiveness of EQ-5D utility scores in patients with depression: A comparison with instruments measuring quality of life, psychopathology and social functioning.
    Günther OH; Roick C; Angermeyer MC; König HH
    J Affect Disord; 2008 Jan; 105(1-3):81-91. PubMed ID: 17532051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why do patients with inflammatory arthritis often score states "worse than death" on the EQ-5D? An Investigation of the EQ-5D classification system.
    Harrison MJ; Davies LM; Bansback NJ; McCoy MJ; Farragher TM; Verstappen SM; Hassell A; Symmons DP
    Value Health; 2009 Sep; 12(6):1026-34. PubMed ID: 19473335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping oral health related quality of life to generic health state values.
    Brennan DS; Spencer AJ
    BMC Health Serv Res; 2006 Aug; 6():96. PubMed ID: 16893470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scale characteristics and mapping accuracy of the US EQ-5D, UK EQ-5D, and SF-6D in patients with rheumatoid arthritis.
    Wolfe F; Michaud K; Wallenstein G
    J Rheumatol; 2010 Aug; 37(8):1615-25. PubMed ID: 20551106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Health State Utility Measures in Patients With Head and Neck Cancer.
    Noel CW; Lee DJ; Kong Q; Xu W; Simpson C; Brown D; Gilbert RW; Gullane PJ; Irish JC; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
    JAMA Otolaryngol Head Neck Surg; 2015 Aug; 141(8):696-703. PubMed ID: 26204439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the Health-Related Quality of Life of Australian Adolescents: An Empirical Comparison of the Child Health Utility 9D and EQ-5D-Y Instruments.
    Chen G; Flynn T; Stevens K; Brazier J; Huynh E; Sawyer M; Roberts R; Ratcliffe J
    Value Health; 2015 Jun; 18(4):432-8. PubMed ID: 26091597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping the 25-item National Eye Institute Visual Functioning Questionnaire (NEI VFQ-25) to EQ-5D utility scores.
    Kay S; Ferreira A
    Ophthalmic Epidemiol; 2014 Apr; 21(2):66-78. PubMed ID: 24568628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating EuroQol EQ-5D scores from Population Healthy Days data.
    Jia H; Lubetkin EI
    Med Decis Making; 2008; 28(4):491-9. PubMed ID: 18556640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population.
    Petrou S; Hockley C
    Health Econ; 2005 Nov; 14(11):1169-89. PubMed ID: 15942981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The validity of EQ-5D US preference weights in liver transplant candidates and recipients.
    Russell RT; Feurer ID; Wisawatapnimit P; Pinson CW
    Liver Transpl; 2009 Jan; 15(1):88-95. PubMed ID: 19109831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation and comparison of EuroQol and short form 6D in chronic prostatitis patients.
    Zhao FL; Yue M; Yang H; Wang T; Wu JH; Li SC
    Value Health; 2010 Aug; 13(5):649-56. PubMed ID: 20412540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.